About us
ATMP Sweden is a national coordination and communication network aimed at accelerating patient access to safe and effective medicines based on recombinant genes, live cells an/or tissue engineering. This new class of medicines are classified as Advanced Therapy Medicinal Products (ATMPs) by the European Medicines Agency.
We act as a central contact point both nationally and internationally for the Swedish ATMP field. Contact us!
Stay up to date!
ATMP Sweden runs the annual Swedish conference ATMP Sweden and the ATMP World Tour. We also maintain the atmp.knowitjonkoping.se website, the ATMP Sweden Linkedin page and the ATMP Sweden newsletter – a quarterly newsletter updating on Swedish ATMP developments.
We aim to make Sweden world leading in ATMP by 2030!
National Initiatives
At ATMP Sweden we assist in coordinating interactions between Nationally funded initiatives working in different areas of ATMP development to ensure that together we develop effective processes for GMP translation, clinical trials, market approval and reimbursement, enable the greatest possible access for Swedish patients to these innovative medicines.
There are now many National initiatives supported by ATMP Sweden including;
- CAMP – science and technology to translate ATMPs from lab to clinic, including bioprocess development, GMP production and logistics.
- ATMP2030 – towards transformation of the systems to make Sweden world leading in ATMP by 2030
- SWECARNET – network for clinical use of CAR T cells
- IndiCell – Innovation Millieu for developing state-of-the-art workflows for manufacture of hPSC derived cell therapies
- NextGenNK – focused on cost effective development of Natural Killer (NK) cell based therapies
- CCRM Nordic
- National Research School
- Innovation Hub – production of Advanced Therapy Medicinal Products (ATMPs) and DNA and RNA based vaccines.
- GeneNova – for developing safer, more efficacious and accessible AAV based gene therapies
History
The ATMP Sweden network was founded through the communications workpage of the Vinnova funded project Swelife-ATMP. At the time, the Centre for Advanced Medicinal Products (CAMP) was the only other National ATMP initiative and both initiatives developed the initial website atmp.knowitjonkoping.se and National annual conference ”ATMP Sweden”, together. ATMP Sweden is now supported by the ”National Coordination” project of the Vinnova funded ATMP2030 Innovation Millieu.
Related content
Help us to revolutionise healthcare! Build a partnership with our organisation.
View contact information for ATMP Sweden and related projects.